[75] suggested that MDH can be utilized as a novel enzymatic serum liver biomarker
The implications of GLP-1 drugs are far-reaching: if issues of cost and access can be managed, these medications could significantly reduce the burden of type 2 diabetes, cardiovascular disease, and obesity-related complications on a global scale
To test our hypotheses about perceptions of the targets SES, we used two-tailed independent samples t-tests to compare scores from participants in the GLP-1 and diet+exercise conditions
Many patients experience more noticeable weight loss as their dose is gradually increased
Cohort identification The background population of patients with diabetes mellitus was selected among Italian citizens residing in Veneto who had been eligible beneficiaries for at least 1 year between January 1st, 2011 and September 30th, 2018 or time of death
Known for her patient-centered approach, Dr